Physician profile
Robert D Butcher
NPI 1952394223
$4,256.51
in general payments reported to CMS, 2019-2025
10 companies · $824 in 2025
The $824 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $508 · 2021: $319 · 2022: $582 · 2023: $893 · 2024: $405 · 2025: $824.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,121.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,121.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $1,613.68 | 2022-2025 | Infuse, Biotrue, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $886.05 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $588.86 | 2019-2025 | Acuvue |
| Alcon Vision LLC | $516.50 | 2019-2025 | Hydrus Microstent, Total30, Precision7 |
| Coopervision INC. | $357.27 | 2019-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Tarsus Pharmaceuticals, INC. | $146.27 | 2024 | Xdemvy |
| Ani Pharmaceuticals, INC. | $45.12 | 2025 | Iluvien, Yutiq |
| Dompe US, INC. | $44.48 | 2024-2025 | Oxervate |
| Biotissue Holdings INC. | $36.25 | 2019 | |
| Sun Pharmaceutical Industries INC. | $22.03 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Butcher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.